Browsing by Author Gianni, Lorenzo

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 8 of 8
Issue DateTitleAuthor(s)Citation
2013Adjuvant pegylated liposomal doxorubicin for older women with endocrine nonresponsive breast cancer who are NOT suitable for a "standard chemotherapy regimen": The CASA randomized trialCoates, Alan; Crivellari, Diana; Dellapasqua, S; et al, Various; Gianni, Lorenzo; Gray, Kathryn P; Lang, Istvan; Pinotti, Graziella; Price, Karen N; Puglisi, Fabio; Ribi, Karin; Spazzapan, Simon; School of Public Health: Public HealthAdjuvant pegylated liposomal doxorubicin for older women with endocrine nonresponsive breast cancer who are NOT suitable for a "standard chemotherapy regimen": The CASA randomized trial, The Breast, vol.22, 2, 2013,pp 130-137
2008Anemia during adjuvant non-taxane chemotherapy for early breast cancer: Incidence and risk factors from two trials of the International Breast Cancer Study GroupCoates, Alan; Aebi, Stefan; Byrne, Michael J.; Cole, Bernard; Colleoni, Marco; Crivellari, Diana; et, al; Gianni, Lorenzo; Holmberg, Stig B.; Panzini, Ilaria; Snyder, Raymond; School of Public Health: Public HealthAnemia during adjuvant non-taxane chemotherapy for early breast cancer: Incidence and risk factors from two trials of the International Breast Cancer Study Group, Supportive Care in Cancer, vol.16,(1),2008,pp 67-74
2016Annual hazard rates of recurrence for breast cancer during 24 years of follow-up: Results from the international breast cancer study group trials I to VCoates, Alan; Castiglione-Gertsch, Monica; Colleoni, Marco; Forbes, John F.; Gelber, Richard; Gianni, Lorenzo; Goldhirsch, Aron; Karlsson, Per; Price, Karen; Sun, Zhuoxin; Thurlimann, B.; School of Public Health: Public HealthAnnual hazard rates of recurrence for breast cancer during 24 years of follow-up: Results from the international breast cancer study group trials I to V, Journal of Clinical Oncology, vol.34, 9, 2016,pp 927-935
2016Low-dose oral cyclophosphamide and methotrexate maintenance for hormone receptor-negative early breast cancer: International Breast Cancer Study Group Trial 22-00Coates, Alan; Abdi, Ehtesham A; Colleoni, Marco; et al, Various; Gelber, S.; Gianni, Lorenzo; Gomez, Henry; Gray, Katherine P; Lang, Istvan; Linderholm, Barbro K; Thurlimann, Beat; School of Public Health: Public HealthLow-dose oral cyclophosphamide and methotrexate maintenance for hormone receptor-negative early breast cancer: International Breast Cancer Study Group Trial 22-00, Journal of Clinical Oncology, vol.34, 28, 2016,pp 3400-3408
2016Low-dose oral cyclophosphamide and methotrexate maintenance for hormone receptor-negative early breast cancer: International Breast Cancer Study Group Trial 22-00Coates, Alan; Abdi, Ehtesham A; Colleoni, Marco; et al, Various; Gelber, S.; Gianni, Lorenzo; Gomez, Henry; Gray, Katherine P; Lang, Istvan; Linderholm, Barbro K; Thurlimann, Beat; School of Public Health: Public HealthLow-dose oral cyclophosphamide and methotrexate maintenance for hormone receptor-negative early breast cancer: International Breast Cancer Study Group Trial 22-00, Journal of Clinical Oncology, vol.34, 28, 2016,pp 3400-3408
2006Ocular toxicity during adjuvant chemoendocrine therapy for early breast cancer - Results from International Breast Cancer Study Group Trials.Coates, Alan; Castiglione-Gertsch, Monica; Collins, John; Crivellari, Diana; Gelber, Richard D. (Prof); Gianni, Lorenzo; Goldhirsch, Aron (Prof); Holmberg, Stig B.; Li, Sigui; Panzini, Ilaria; Ravaioli, Alberto; School of Public Health: Public HealthOcular toxicity during adjuvant chemoendocrine therapy for early breast cancer - Results from International Breast Cancer Study Group Trials., Cancer, vol.106,(3),2006,pp 505-513
2008p27 and Skp2 immunoreactivity and its clinical significance with endocrine and chemo-endocrine treatments in node-negative early breast cancer.Coates, Alan; Castiglione-Gertsch, Monica; Gianni, Lorenzo; Goldhirsch, Aron; Gusterson, Barry; Maffini, Fausto; Mastropasqua, M; Monti, F; Panzini, Ilaria; Price, Karen; Ravaioli, A; Regan, Meredith M.; Spataro, Vito J.; Viale, Giuseppe; School of Public Health: Public Healthp27 and Skp2 immunoreactivity and its clinical significance with endocrine and chemo-endocrine treatments in node-negative early breast cancer., Annals of Oncology, vol.19, 4, 2008,pp 660-668
2009Second non-breast primary cancer following adjuvant therapy for early breast cancer: a report from the International Breast Cancer Study Group.Coates, Alan; Castiglione-Gertsch, Monica; Fantini, Manuela; Gelber, Richard D. (Prof); Gelber, Shari; Gianni, Lorenzo; Goldhirsch, A; Pagani, O.; Panzini, Ilaria; Price, Karen N.; Ravaioli, Alberto; Simoncini, Edda; School of Public Health: Public HealthSecond non-breast primary cancer following adjuvant therapy for early breast cancer: a report from the International Breast Cancer Study Group., European Journal of Cancer, vol.45, 4,pp 561-571